Accessibility Menu
 
Pennant Group logo

Pennant Group

(NASDAQ) PNTG

Current Price$29.70
Market Cap$1.03B
Since IPO (2019)+97%
5 Year-36%
1 Year+16%
1 Month-10%

Pennant Group Financials at a Glance

Market Cap

$1.03B

Revenue (TTM)

$947.71M

Net Income (TTM)

$29.58M

EPS (TTM)

$0.84

P/E Ratio

35.42

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$29.70

Volume

9,654

Open

$30.20

Previous Close

$29.70

Daily Range

$29.60 - $30.32

52-Week Range

$21.73 - $35.00

PNTG News

PNTG: Motley Fool Moneyball Superscore

72

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pennant Group

Industry

Healthcare Providers and Services

Employees

9,700

CEO

Brent J. Guerisoli, MBA

Headquarters

Eagle, ID 83616, US

PNTG Financials

Key Financial Metrics (TTM)

Gross Margin

15%

Operating Margin

6%

Net Income Margin

3%

Return on Equity

9%

Return on Capital

6%

Return on Assets

3%

Earnings Yield

2.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.03B

Shares Outstanding

34.66M

Volume

9.65K

Short Interest

0.00%

Avg. Volume

298.92K

Financials (TTM)

Gross Profit

$122.47M

Operating Income

$51.39M

EBITDA

$60.85M

Operating Cash Flow

$48.29M

Capital Expenditure

$22.00M

Free Cash Flow

$26.30M

Cash & ST Invst.

$17.02M

Total Debt

$453.16M

Pennant Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$289.32M

+53.2%

Gross Profit

$37.42M

+49.6%

Gross Margin

12.93%

N/A

Market Cap

$1.03B

N/A

Market Cap/Employee

$146.87K

N/A

Employees

7,000

N/A

Net Income

$8.64M

+50.0%

EBITDA

$19.88M

+79.5%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$436.14M

-75.3%

Accounts Receivable

$123.11M

+51.4%

Inventory

$0.00

N/A

Long Term Debt

$423.15M

+67.0%

Short Term Debt

$30.01M

+52.6%

Return on Assets

3.06%

N/A

Return on Invested Capital

6.39%

N/A

Free Cash Flow

$13.97M

-19.0%

Operating Cash Flow

$20.96M

+1.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INNVInnovAge Holding Corp.
$7.61-5.11%
EYPTEyePoint Pharmaceuticals, Inc.
$13.40+2.92%
BCAXBicara Therapeutics Inc. Common Stock
$21.47+4.73%
KURAKura Oncology, Inc.
$8.61+3.24%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.31-0.02%

Questions About PNTG

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.